Effects of irradiated glucose solutions on DMBA-induced tumors in rats.
DOI:
https://doi.org/10.20344/amp.3881Abstract
This is a study of the effects of irradiated glucose-saline solutions (60Co, 105 R at a dose rate of 1.7 X 106 R/h) on tumors induced by the intravenous injection of dimethylbenzanthracene (DMBA) in female Sprague-Dawley rats. Each animal received 10 cc intraperitoneal injections of the irradiated solution spaced over 17 days. As a control two groups of tumor bearing animals were used: one received irradiated isotonic saline solution, and the other unirradiated glucose-saline solution. It could be concluded that those animals which received the irradiated glucose-saline solution experienced retardation of the tumor disease both during and after the treatment period relative to the other groups under study. The results suggest that radiolysis of hexoses can give rise to a carcinostatic compound relatively non-toxic toward non-dividing cells.
Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.